MedPath

Comparison of intravenous enoxaparin with subcutaneous enoxaparin in preventing venous thromboembolism

Not Applicable
Conditions
Intravenous thromboembolism.
Registration Number
IRCT20191012045075N1
Lead Sponsor
Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Ages 18 to 70 years
Hospitalization for at least 48 hours in ICU
Mechanical ventilation
Normal renal and hepatic function
Passing 48 hours from surgery in patients with intracerebral hemorrhage (epidural , subdural and intracerebral hematoma and hemorrhagic stroke)

Exclusion Criteria

History of deep vein thrombosis
History of pulmonary embolism
History of coagulation disorders (hemophilia, disseminated intravascular coagulation, idiopathic thrombocytopenia, heparin- induced thrombocytopenia and disruption of coagulation tests)
Treated with other anticoagulants before hospitalization
Prosthetic implantation (artificial heart valve, stent and IVC filter)
Myelodysplastic syndrome and other blood dyscrasias

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath